Skip to main content

Table 2 IVF outcome of the patients included in the study

From: A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments

 

Group A

Group B

Group C

Group D

IVF cycles

52

56

44

200

Total Gn dose (IU)

3714 +/- 1499 c

3430 +/- 1722

3000 +/- 1358 b

2755 +/- 1216 a

Stimulation length (d)

12.3 +/- 2.1

12.2 +/- 2.5

11.4 +/- 1.6 b

11.5 +/- 1.8 b

OPU

50

55

44

200

Retrieved oocytes

6.5 +/- 4.3

7.9 +/- 5.4

10.7 +/- 6.4 b

8.7 +/- 5.2 b

Gn dose/oocyte (IU)

1028 +/- 1141

878 +/- 1045

448 +/- 520 b

539 +/- 796 b

Fertilization rate (%)

74.2

78.5

82.5

83.0

ET

40

45

39

177

Pregnancies

4

11

14

66

PR/started cycle (%)

7.7 c

19.6

31.8 b

33.0 b

PR/OPU (%)

8.0 c

20.0

31.8 b

33.3 b

PR/ET (%)

10.0 c

24.4

35.9 b

37.3 b

Implantation rate (%)

4.7 c

14.4

17.7 b

19.0 a

Abortions

1

3

4

8

Abortion rate (%)

25.0

27.3

28.5

12.0 a

Ongoing PR/OPU (%)

6.0 c

14.5

22.7 b

29.3 b

Ongoing PR/ET (%)

7.5 c

17.8

25.6 b

32.8 b

  1. Group A: ATA+, untreated patients. Group B: ATA+ patients treated with LT adjuvant therapy. Group C: ATA+ patients treated with LT+ASA+P adjuvant therapy; Group D: ATA-controls.
  2. a = p < 0.01 vs groups A, B and C
  3. b = p < 0.01 vs groups A, and B
  4. c = p < 0.01 vs group B and C